Clinical Trial Update: First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data

View source ↗

Summary

This clinical trial update announces completion of arrhythmia data collection from both transvenous and subcutaneous implantable cardioverter-defibrillators.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Status: COMPLETED